PL371788A1 - Kompozycje farmaceutyczne i kosmetyczne zawierające PLGF-1 - Google Patents

Kompozycje farmaceutyczne i kosmetyczne zawierające PLGF-1

Info

Publication number
PL371788A1
PL371788A1 PL03371788A PL37178803A PL371788A1 PL 371788 A1 PL371788 A1 PL 371788A1 PL 03371788 A PL03371788 A PL 03371788A PL 37178803 A PL37178803 A PL 37178803A PL 371788 A1 PL371788 A1 PL 371788A1
Authority
PL
Poland
Prior art keywords
plgf
pharmaceutical
cosmetic compositions
cosmetic
compositions
Prior art date
Application number
PL03371788A
Other languages
English (en)
Inventor
Domenico Maglione
Mauro Battisti
Ettore Conti
Giuseppe Salvia
Marina Tucci
Original Assignee
Geymonat S.P.A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11456138&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL371788(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Geymonat S.P.A filed Critical Geymonat S.P.A
Publication of PL371788A1 publication Critical patent/PL371788A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1858—Platelet-derived growth factor [PDGF]
    • A61K38/1866—Vascular endothelial growth factor [VEGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Vascular Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Birds (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PL03371788A 2002-03-05 2003-03-05 Kompozycje farmaceutyczne i kosmetyczne zawierające PLGF-1 PL371788A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2002RM000119A ITRM20020119A1 (it) 2002-03-05 2002-03-05 Composizioni contenenti plgf ad uso farmaceutico e cosmetico.

Publications (1)

Publication Number Publication Date
PL371788A1 true PL371788A1 (pl) 2005-06-27

Family

ID=11456138

Family Applications (1)

Application Number Title Priority Date Filing Date
PL03371788A PL371788A1 (pl) 2002-03-05 2003-03-05 Kompozycje farmaceutyczne i kosmetyczne zawierające PLGF-1

Country Status (20)

Country Link
US (1) US7364722B2 (pl)
EP (1) EP1482967B1 (pl)
JP (2) JP5010093B2 (pl)
KR (1) KR100988656B1 (pl)
CN (1) CN100467058C (pl)
AU (1) AU2003217464B2 (pl)
BR (1) BR0308040A (pl)
CA (1) CA2477075C (pl)
CY (1) CY1114209T1 (pl)
DK (1) DK1482967T3 (pl)
ES (1) ES2424827T3 (pl)
HR (1) HRP20040914A2 (pl)
IT (1) ITRM20020119A1 (pl)
MX (1) MXPA04008486A (pl)
PL (1) PL371788A1 (pl)
PT (1) PT1482967E (pl)
RU (1) RU2292906C2 (pl)
SI (1) SI1482967T1 (pl)
WO (1) WO2003074075A1 (pl)
ZA (1) ZA200407707B (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2872040B1 (fr) * 2004-06-23 2006-09-22 Centre Nat Rech Scient Cnrse Utilisation cosmetique d'au moins un tetrapeptide naturel ac-n-ser-asp-lys-pro- ou un de ses analogues en tant qu'agent antivieillissement et restructurant de la peau
US8057458B2 (en) * 2006-10-30 2011-11-15 Warsaw Orthopedic, Inc. Method for treating facet pain
EP2394666A2 (en) * 2009-02-05 2011-12-14 Digna Biotech, S.L. Pharmaceutical compositions comprising tgf- beta 1 inhibitor peptides
US8741850B2 (en) 2009-07-24 2014-06-03 Advanced Accelerator Applications S.A. Compounds modulators of VEGF activity and uses thereof
WO2014117155A1 (en) * 2013-01-28 2014-07-31 Shire Human Genetic Therapies, Inc. Placenta growth factor in treating duchenne muscular dystrophy
WO2015109329A1 (en) 2014-01-17 2015-07-23 Mimedx Group, Inc. Method for inducing angiogenesis

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1283892A (en) * 1970-06-08 1972-08-02 Irwin Irville Lubowe Improvements in and relating to medicinal compositions for application to the skin and/or hair
IT1242149B (it) * 1990-09-27 1994-02-16 Consiglio Nazionale Ricerche Sequenza di nucleotidi codificante per una proteina umana con proprieta' regolative dell'angiogenesi
CA2229479C (en) * 1995-08-15 2010-03-30 Connective Therapeutics, Inc. Method of promoting angiogenesis
RU2102091C1 (ru) * 1995-09-19 1998-01-20 Казанский медицинский университет Способ лечения системной склеродермии
AU7003096A (en) * 1996-06-21 1998-01-07 Jury Evgenievich Belyaev Semi-finished product for producing drug bases, bases obtained using the same and variants, and drugs obtained using these bases and variants
CA2315977A1 (en) * 1997-12-24 1999-07-08 Ludwig Institute For Cancer Research Expression vectors and cell lines expressing vascular endothelial growth factor d, and method of treating melanomas
CA2377435A1 (en) * 1999-06-29 2001-01-04 J. Alexander Marchosky Compositions and methods for forming and strengthening bone
JP3877914B2 (ja) * 1999-09-07 2007-02-07 サンスター株式会社 皮膚化粧料
WO2001057181A2 (en) * 2000-02-04 2001-08-09 Carmeliet, Peter Use of vascular endothelial growth factor, placenta growth factor or both for preventing or treating ischemic diseases or stroke
JP2001316242A (ja) * 2000-03-02 2001-11-13 Noevir Co Ltd 皮膚外用剤
EP1267800A4 (en) * 2000-03-31 2004-08-25 Gen Hospital Corp METHOD FOR INFLUENCING HAIR GROWTH

Also Published As

Publication number Publication date
JP2005519101A (ja) 2005-06-30
JP2010116405A (ja) 2010-05-27
AU2003217464A1 (en) 2003-09-16
HK1078469A1 (zh) 2006-03-17
RU2292906C2 (ru) 2007-02-10
ITRM20020119A1 (it) 2003-09-05
US7364722B2 (en) 2008-04-29
CN1638793A (zh) 2005-07-13
CY1114209T1 (el) 2016-08-31
KR20040111379A (ko) 2004-12-31
ES2424827T3 (es) 2013-10-08
EP1482967B1 (en) 2013-05-15
DK1482967T3 (da) 2013-08-26
BR0308040A (pt) 2004-12-14
AU2003217464B2 (en) 2007-08-30
US20050239698A2 (en) 2005-10-27
CA2477075A1 (en) 2003-09-12
HRP20040914A2 (en) 2004-12-31
SI1482967T1 (sl) 2013-10-30
ITRM20020119A0 (it) 2002-03-05
US20050075288A1 (en) 2005-04-07
JP5144690B2 (ja) 2013-02-13
EP1482967A1 (en) 2004-12-08
CA2477075C (en) 2013-08-06
WO2003074075A1 (en) 2003-09-12
MXPA04008486A (es) 2005-04-19
CN100467058C (zh) 2009-03-11
JP5010093B2 (ja) 2012-08-29
ZA200407707B (en) 2005-07-27
KR100988656B1 (ko) 2010-10-18
PT1482967E (pt) 2013-08-27
RU2004129586A (ru) 2005-06-10

Similar Documents

Publication Publication Date Title
IL168399A0 (en) Cosmetic and pharmaceutical foam
IL173726A (en) Pharmaceutical compositions containing n-n-dihaloamino acids and their uses
IL162548A0 (en) 4-Oxoquinoline derivatives and pharmaceutical compositions containing the same
IL173093A0 (en) Oleaginous pharmaceutical and cosmetic foam
HUP0400384A3 (en) Benzamidine derivative and pharmaceutical compositions containing them and their use
PL378135A1 (pl) 2-Cyjanopirolopirymidyny i ich zastosowania w farmaceutykach
IL166482A0 (en) Dihydropyrazolopyridine derivatives and pharmaceutical compositions containing the same
AU2003220361A8 (en) Benzamides and compositions benzamides for use as fungizide
IL163868A (en) Hemiasterlin derivatives and pharmaceutical compositions comprising them
IL170313A (en) Diarylcycloalkyl derivatives and pharmaceutical compositions comprising them
IL168477A (en) Isoindoline derivatives and pharmaceutical compositions comprising them
GB0108470D0 (en) Pharmaceutical compositions and their use
IL176384A (en) Pyrrolidinochlorinated basazole and pharmacy preparations containing them
GB0208081D0 (en) Skincare compositions and methods
AU2004313285A1 (en) Oleaginous pharmaceutical and cosmetic foam
HUP0304077A3 (en) Pharmaceutical and cosmetic compositions against skin aging
AU2003296369A8 (en) Imminoamines and preparation thereof
AU2003213120A8 (en) Human rnase iii and compositions and uses thereof
EP1539191A4 (en) COMPOSITIONS CONTAINING GLYCO ALKALOIDS AND THEIR VARIOUS USES
GB2384705B (en) Cosmetic and related compositions
SI1482967T1 (sl) Farmacevtski in kozmetični sestavki, ki vsebujejo PLGF-1
IL173626A0 (en) Small peptides and oral pharmaceutical compositions containing the same
IL153176A (en) Phenylpiperazines and pharmaceutical compositions comprising them
AU2003228896A8 (en) Anti-microbial peptides and compositions
GB0207224D0 (en) Tenascin-W compositions and uses thereof